Brief: Genscript Biotech Corp Sees An Adjusted Loss Of About US$154.5 Million To US$193.3 Million For Year
Feb 19 (Reuters) - Genscript Biotech Corp 1548.HK :
* SEES AN ADJUSTED LOSS OF ABOUT US$154.5 MILLION TO
US$193.3
MILLION FOR YEAR
* SEES A LOSS OF ABOUT US$270.2 MILLION TO US$306.0 MILLION
FOR
YEAR
Source text for Eikon: urn:newsml:reuters.com:*:nHKS1kmC59
Further company coverage: 1548.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale